# ZCCHC12

## Overview
ZCCHC12 is a gene located on the X chromosome that encodes the zinc finger CCHC-type containing 12 protein, also known as Smad-interacting zinc finger protein 1 (Sizn1). This protein is characterized by a CCHC-type zinc finger motif, which is crucial for its role as a transcriptional co-activator in various signaling pathways, including bone morphogenetic protein (BMP) signaling. ZCCHC12 interacts with transcription factors such as activator protein 1 (AP-1) and cAMP response element binding protein (CREB), enhancing their transcriptional activities, particularly in the nervous system. The protein is predominantly expressed in the brain and is implicated in brain development and oncogenesis, notably in papillary thyroid cancer. Its involvement in neurological disorders and cancer highlights its potential as a therapeutic target and diagnostic marker (Li2009Human; Yin2023Differential; Wang2021The).

## Structure
The ZCCHC12 protein, also known as Smad-interacting zinc finger protein 1 (Sizn1), is a 402-amino acid protein encoded by the ZCCHC12 gene located on the X chromosome (Li2009Human). The primary structure of ZCCHC12 includes a CCHC-type zinc finger motif characterized by the sequence Cys-X2-Cys-X4-His-X4-Cys, which is known for its nucleic acid binding activity, essential for RNA binding and genomic packaging (Li2009Human). The protein also contains two nuclear localization signals (NLSs) that facilitate its nuclear localization, as confirmed by immunofluorescent staining showing a nuclear punctate distribution (Li2009Human).

ZCCHC12 functions as a transcriptional co-activator, enhancing the transcriptional activities of activator protein 1 (AP-1) and cAMP response element binding protein (CREB) through interaction with c-Jun, a component of AP-1 (Li2009Human). The protein is highly conserved among higher animals, indicating its specialized functions, particularly in the brain (Li2009Human). While specific details on the secondary, tertiary, and quaternary structures are not provided, the presence of the zinc finger motif suggests a role in maintaining the structural integrity necessary for its function as a transcriptional co-activator.

## Function
ZCCHC12, also known as Sizn1, functions as a transcriptional co-activator in bone morphogenetic protein (BMP) signaling. It interacts with the Smad complex, which binds directly to DNA, facilitating transcription initiation by recruiting transcriptional co-activators or co-repressors. ZCCHC12 does not directly bind to DNA or RNA but associates with DNA through interactions with Smad1 and CBP, a chromatin-modifying enzyme, thereby positively regulating Smad1-mediated transcription (Wang2021The).

In the nucleus, ZCCHC12 enhances the transcriptional activities of activator protein 1 (AP-1) and cAMP response element binding protein (CREB), which are crucial transcription factors in the nervous system. It interacts with c-Jun, a component of AP-1, suggesting it acts as a co-activator in transcription regulation (Li2009Human). ZCCHC12 contains two nuclear localization signals necessary for its nuclear localization, as demonstrated in various human cell lines (Li2009Human).

ZCCHC12 is primarily expressed in the human brain and is implicated in brain development, as evidenced by its expression in the neuroepithelium of mouse embryos (Li2009Human). It is also associated with oncogenesis in papillary thyroid cancer and specific gene expression in basal forebrain cholinergic neurons (Wang2021The).

## Clinical Significance
Alterations in the expression of the ZCCHC12 gene have been implicated in several diseases, particularly in neurological and cancer-related conditions. ZCCHC12, also known as Smad-interacting zinc finger protein 1 (Sizn1), is associated with non-syndromic X-linked mental retardation (NS-XLMR). Variants of the ZCCHC12 gene have been identified in individuals with NS-XLMR, suggesting its role as a candidate gene for this condition (Li2009Human; Cho2008Evidence).

In the context of cancer, ZCCHC12 has been identified as a novel oncogene in papillary thyroid carcinoma (PTC). Studies have shown that ZCCHC12 is significantly overexpressed in PTC tumor samples compared to non-cancerous tissues. This overexpression is linked to an increased risk of lymph node metastasis, indicating its role in cancer progression and metastasis (Yang2021A; Wang2017ZCCHC12). Additionally, ZCCHC12 expression is associated with tumor immunity in thyroid carcinoma, correlating with various immune cell types and potentially serving as a biomarker for disease progression (Yin2023Differential).

These findings highlight the clinical significance of ZCCHC12 in both neurological disorders and cancer, underscoring its potential as a therapeutic target and diagnostic marker.

## Interactions
ZCCHC12, also known as Sizn1, is a transcriptional co-activator involved in bone morphogenic protein (BMP) signaling. It interacts with Smad1 and the chromatin-modifying enzyme CBP, facilitating transcription initiation. The N-terminus of ZCCHC12 interacts with CBP, while the C-terminus associates with Smad1. These interactions occur in vivo, although ZCCHC12 does not directly bind to DNA or RNA in vitro. ZCCHC12 localizes to promyelocytic leukemia protein nuclear bodies (PML-NBs) through two SUMO interaction motifs (SIMs) and the MA homologous domain, with the SIMs being essential for full co-activation of the BMP signaling pathway (Wang2021The).

ZCCHC12 also activates transcriptional activities mediated by transcription factors such as c-Jun, AP-1, and CREB, with CBP serving as a co-activator in these processes (Wang2021The). In the context of papillary thyroid cancer, ZCCHC12 is overexpressed and associated with tumor progression, suggesting its role as a metastasis-related oncogene, although specific interactions in this context are not detailed (Wang2017ZCCHC12). The protein is part of the Paraneoplastic Ma Antigen (PNMA) family, which is linked to Paraneoplastic Neuronal Disorder, indicating a potential oncogenic role (AceitunoValenzuela2020Genomewide).


## References


[1. (Li2009Human) Hong Li, Qian Liu, Xiang Hu, Du Feng, Shuanglin Xiang, Zhicheng He, Xingwang Hu, Jianlin Zhou, Xiaofeng Ding, Chang Zhou, and Jian Zhang. Human zcchc12 activates ap-1 and creb signaling as a transcriptional co-activator. Acta Biochimica et Biophysica Sinica, 41(7):535–544, July 2009. URL: http://dx.doi.org/10.1093/abbs/gmp042, doi:10.1093/abbs/gmp042. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/abbs/gmp042)

[2. (Yin2023Differential) Yin Yin, Jing Chen, Qian Chen, Hongyan He, Nannan Zhu, Pengcheng Xia, Chunli Yu, and Lingyun Meng. Differential expression of zinc finger cchc-type superfamily proteins in thyroid carcinoma and their associations with tumor immunity. Thyroid Research, October 2023. URL: http://dx.doi.org/10.1186/s13044-023-00185-1, doi:10.1186/s13044-023-00185-1. This article has 0 citations.](https://doi.org/10.1186/s13044-023-00185-1)

[3. (Yang2021A) Yarong Yang, Wenjuan Hua, Mei Zeng, Liling Yu, Baijun Zhang, and Liming Wen. A cerna network mediated by linc00475 in papillary thyroid carcinoma. Open Medicine, 17(1):22–33, December 2021. URL: http://dx.doi.org/10.1515/med-2021-0389, doi:10.1515/med-2021-0389. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/med-2021-0389)

[4. (Wang2017ZCCHC12) Ouchen Wang, Zhouci Zheng, Qingxuan Wang, Yixiang Jin, Wenxu Jin, Yinghao Wang, Endong Chen, and Xiaohua Zhang. Zcchc12, a novel oncogene in papillary thyroid cancer. Journal of Cancer Research and Clinical Oncology, 143(9):1679–1686, April 2017. URL: http://dx.doi.org/10.1007/s00432-017-2414-6, doi:10.1007/s00432-017-2414-6. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-017-2414-6)

[5. (Cho2008Evidence) Ginam Cho, Shambhu S. Bhat, Jinsong Gao, Julianne S. Collins, R. Curtis Rogers, Richard J. Simensen, Charles E. Schwartz, Jeffrey A. Golden, and Anand K. Srivastava. Evidence that sizn1 is a candidate x‐linked mental retardation gene. American Journal of Medical Genetics Part A, 146A(20):2644–2650, September 2008. URL: http://dx.doi.org/10.1002/ajmg.a.32472, doi:10.1002/ajmg.a.32472. This article has 21 citations.](https://doi.org/10.1002/ajmg.a.32472)

[6. (Wang2021The) Yishu Wang, Yu Yu, Yidan Pang, Haojun Yu, Wenqi Zhang, Xian Zhao, and Jianxiu Yu. The distinct roles of zinc finger cchc-type (zcchc) superfamily proteins in the regulation of rna metabolism. RNA Biology, 18(12):2107–2126, May 2021. URL: http://dx.doi.org/10.1080/15476286.2021.1909320, doi:10.1080/15476286.2021.1909320. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15476286.2021.1909320)

[7. (AceitunoValenzuela2020Genomewide) Uri Aceituno-Valenzuela, Rosa Micol-Ponce, and María Rosa Ponce. Genome-wide analysis of cchc-type zinc finger (zcchc) proteins in yeast, arabidopsis, and humans. Cellular and Molecular Life Sciences, 77(20):3991–4014, April 2020. URL: http://dx.doi.org/10.1007/s00018-020-03518-7, doi:10.1007/s00018-020-03518-7. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-020-03518-7)